Farmax Retail India gets approval for Rs. 5 billion in convertibles

By Devika Patel

Knoxville, Tenn., Jan. 4 - Farmax Retail India Ltd. informed the Bombay Stock Exchange that it approved plans to sell up to Rs. 5 billion in foreign currency convertible bonds at an extraordinary general meeting on Jan. 1.

The company also is considering Global Depositary Receipts.

Based in Hyderabad, India, Farmax manufactures health products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.